posted on 2025-11-06, 16:45authored byYu Kuei Lin, Haoran Tang, Wen Ye, Alexandria Ratzki-Leewing, Joyce Lee, Nicole de Zoysa, Stephanie A. Amiel, William H. Herman
<p dir="ltr">Recent data indicate that severe hypoglycemia (SH) persists in individuals with insulin-treated type 2 diabetes, despite using continuous glucose monitoring (CGM)(1). While traditional SH risk factors, such as impaired awareness of hypoglycemia (IAH), are well-studied in non-CGM users(2), their relevance to type 2 diabetes CGM users remains unclear. Also unexamined in this population is the potential role of hypoglycemia beliefs, previously linked to SH risk in CGM users with type 1 diabetes(3), This cross-sectional observational study (University of Michigan Institutional Review Board: HUM#00244387) examined how IAH, hypoglycemia beliefs, and other potential risk factors relate to SH, categorized as (i) ≥1 episode and (ii) ≥2 episodes in the past year, in adults with insulin-treated type 2 diabetes using CGM.</p>
Funding
This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK129724), Michigan Center for Clinical and Translational Research (P30DK092926), and Michigan Diabetes Research Center (P30DK020572). REDCap was supported by the National Center for Advancing translational Sciences (UM1TR004404).